Address
75 State Street
Boston, MA 02109
United States of America (the)
Phone
617 213 5054
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
April 29, 2022
| Name | Title | Pay | Year Born |
| Robert Hershberg | Co-Founder, President, Chief Executive Officer & Chairman of the Board | 694,506 | 1962 |
| Shane A. Maltbie | Chief Financial Officer & Treasurer | 512,375 | 1982 |
| Aditya Kohli | Co-Founder & Director | 1.13M | 1988 |
| Paul S. Bavier | General Counsel, Secretary & Chief Administrative Officer | 0 | 1972 |
| Anju Chatterji | Chief Technology Officer | 0 | N/A |
HilleVax, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the creation and market introduction of innovative vaccines. The company's lead investigational product is HIL-214, a vaccine candidate utilizing virus-like particles, which aims to prevent moderate-to-severe acute gastroenteritis resulting from norovirus infections. Its corporate headquarters are located in Boston, Massachusetts.